Cargando…

Six Laws of Open Source Drug Discovery

Six to swear by! Society needs effective and affordable medicines. We currently have at our disposal essentially one system to discover and develop drugs, and there are many areas where this system struggles to deliver, for example to combat antimicrobial resistance, or tropical diseases, or dementi...

Descripción completa

Detalles Bibliográficos
Autor principal: Todd, Matthew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899868/
https://www.ncbi.nlm.nih.gov/pubmed/31612602
http://dx.doi.org/10.1002/cmdc.201900565
_version_ 1783477227047878656
author Todd, Matthew H.
author_facet Todd, Matthew H.
author_sort Todd, Matthew H.
collection PubMed
description Six to swear by! Society needs effective and affordable medicines. We currently have at our disposal essentially one system to discover and develop drugs, and there are many areas where this system struggles to deliver, for example to combat antimicrobial resistance, or tropical diseases, or dementia. It is sensible to cultivate alternative, competing approaches to drug discovery and development. A genuinely new alternative is to open up the entire research cycle, abandoning secrecy altogether. This “open source” approach has now been trialed and the lessons learned distilled to six laws of operation that help to clarify working practices. This article examines and explains those laws, which can be adopted by anyone wishing to create medicines using an inclusive, public process.[Image: see text]
format Online
Article
Text
id pubmed-6899868
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68998682019-12-19 Six Laws of Open Source Drug Discovery Todd, Matthew H. ChemMedChem Editorial Six to swear by! Society needs effective and affordable medicines. We currently have at our disposal essentially one system to discover and develop drugs, and there are many areas where this system struggles to deliver, for example to combat antimicrobial resistance, or tropical diseases, or dementia. It is sensible to cultivate alternative, competing approaches to drug discovery and development. A genuinely new alternative is to open up the entire research cycle, abandoning secrecy altogether. This “open source” approach has now been trialed and the lessons learned distilled to six laws of operation that help to clarify working practices. This article examines and explains those laws, which can be adopted by anyone wishing to create medicines using an inclusive, public process.[Image: see text] John Wiley and Sons Inc. 2019-10-15 2019-11-06 /pmc/articles/PMC6899868/ /pubmed/31612602 http://dx.doi.org/10.1002/cmdc.201900565 Text en © 2019 The Author. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Todd, Matthew H.
Six Laws of Open Source Drug Discovery
title Six Laws of Open Source Drug Discovery
title_full Six Laws of Open Source Drug Discovery
title_fullStr Six Laws of Open Source Drug Discovery
title_full_unstemmed Six Laws of Open Source Drug Discovery
title_short Six Laws of Open Source Drug Discovery
title_sort six laws of open source drug discovery
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899868/
https://www.ncbi.nlm.nih.gov/pubmed/31612602
http://dx.doi.org/10.1002/cmdc.201900565
work_keys_str_mv AT toddmatthewh sixlawsofopensourcedrugdiscovery